BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 22919030)

  • 1. Erythrocyte density in sickle cell syndromes is associated with specific clinical manifestations and hemolysis.
    Bartolucci P; Brugnara C; Teixeira-Pinto A; Pissard S; Moradkhani K; Jouault H; Galacteros F
    Blood; 2012 Oct; 120(15):3136-41. PubMed ID: 22919030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variation in fetal hemoglobin parameters and predicted hemoglobin S polymerization in sickle cell children in the first two years of life: Parisian Prospective Study on Sickle Cell Disease.
    Maier-Redelsperger M; Noguchi CT; de Montalembert M; Rodgers GP; Schechter AN; Gourbil A; Blanchard D; Jais JP; Ducrocq R; Peltier JY
    Blood; 1994 Nov; 84(9):3182-8. PubMed ID: 7524767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dense red blood cell and oxygen desaturation in sickle-cell disease.
    Di Liberto G; Kiger L; Marden MC; Boyer L; Poitrine FC; Conti M; Rakotoson MG; Habibi A; Khorgami S; Vingert B; Maitre B; Galacteros F; Pirenne F; Bartolucci P
    Am J Hematol; 2016 Oct; 91(10):1008-13. PubMed ID: 27380930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fetal hemoglobin and alpha thalassemia modulate the phenotypic expression of HbSD-Punjab.
    Patel DK; Purohit P; Dehury S; Das P; Dutta A; Meher S; Patel S; Bag S; Mashon RS; Das K
    Int J Lab Hematol; 2014 Aug; 36(4):444-50. PubMed ID: 24245819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological parameters predictive of percent dense red blood cell decrease under hydroxyurea.
    Rakotoson MG; Di Liberto G; Audureau E; Habibi A; Fauroux C; Khorgami S; Hulin A; Loric S; Noizat-Pirenne F; Galacteros F; Bartolucci P
    Orphanet J Rare Dis; 2015 May; 10():57. PubMed ID: 25956133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Men with Sickle Cell Anemia and Priapism Exhibit Increased Hemolytic Rate, Decreased Red Blood Cell Deformability and Increased Red Blood Cell Aggregate Strength.
    Cita KC; Brureau L; Lemonne N; Billaud M; Connes P; Ferdinand S; Tressières B; Tarer V; Etienne-Julan M; Blanchet P; Elion J; Romana M
    PLoS One; 2016; 11(5):e0154866. PubMed ID: 27145183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hematological parameters in sickle cell anemia patients with and without priapism.
    Ahmed SG; Ibrahim UA; Hassan AW
    Ann Saudi Med; 2006; 26(6):439-43. PubMed ID: 17143019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolving treatment paradigms in sickle cell disease.
    Jagadeeswaran R; Rivers A
    Hematology Am Soc Hematol Educ Program; 2017 Dec; 2017(1):440-446. PubMed ID: 29222291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Degree of anemia, indirect markers of hemolysis, and vascular complications of sickle cell disease in Africa.
    Dubert M; Elion J; Tolo A; Diallo DA; Diop S; Diagne I; Sanogo I; Belinga S; Guifo O; Wamba G; Ngo Sack F; Boidy K; Kamara I; Traore Y; Diakite CO; Gbonon V; Faye BF; Seck M; Deme Ly I; Chelo D; N'Guetta R; Diop IB; Gaye B; Jouven X; Ranque B
    Blood; 2017 Nov; 130(20):2215-2223. PubMed ID: 28931524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of classical markers and establishment of the dyslipidemic sub-phenotype of sickle cell anemia.
    Aleluia MM; da Guarda CC; Santiago RP; Fonseca TC; Neves FI; de Souza RQ; Farias LA; Pimenta FA; Fiuza LM; Pitanga TN; Ferreira JR; Adorno EV; Cerqueira BA; Gonçalves MS
    Lipids Health Dis; 2017 Apr; 16(1):74. PubMed ID: 28399852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha thalassemia changes erythrocyte heterogeneity in sickle cell disease.
    Noguchi CT; Dover GJ; Rodgers GP; Serjeant GR; Antonarakis SE; Anagnou NP; Higgs DR; Weatherall DJ; Schechter AN
    J Clin Invest; 1985 May; 75(5):1632-7. PubMed ID: 2581999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemoglobin S polymerization: primary determinant of the hemolytic and clinical severity of the sickling syndromes.
    Brittenham GM; Schechter AN; Noguchi CT
    Blood; 1985 Jan; 65(1):183-9. PubMed ID: 3965046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Priapism in sickle-cell disease: a hematologist's perspective.
    Kato GJ
    J Sex Med; 2012 Jan; 9(1):70-8. PubMed ID: 21554552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severity of Brazilian sickle cell disease patients: severity scores and feasibility of the Bayesian network model use.
    Belini Junior E; Silva DG; Torres Lde S; Okumura JV; Lobo CL; Bonini-Domingos CR
    Blood Cells Mol Dis; 2015 Apr; 54(4):321-7. PubMed ID: 25842370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homozygous sickle cell disease in Uganda and Jamaica a comparison of Bantu and Benin haplotypes.
    Ndugwa C; Higgs D; Fisher C; Hambleton I; Mason K; Serjeant BE; Serjeant GR
    West Indian Med J; 2012 Oct; 61(7):684-91. PubMed ID: 23620965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Priapism in patients with hemolytic disorders: a nationwide retrospective cohort study.
    Tranekær S; Hansen DL; Biemond BJ; Sørensen AL; Glenthøj A; Petersen J; Frederiksen H
    Ann Hematol; 2021 Aug; 100(8):1947-1951. PubMed ID: 34136949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haematological parameters associated with priapism in Nigerian patients with homozygous sickle cell disease.
    Adedeji MO; Onuora VC; Ukoli FA
    J Trop Med Hyg; 1988 Jun; 91(3):157-9. PubMed ID: 2455813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Red blood cells microparticles are associated with hemolysis markers and may contribute to clinical events among sickle cell disease patients.
    Olatunya OS; Lanaro C; Longhini AL; Penteado CFF; Fertrin KY; Adekile A; Saad STO; Costa FF
    Ann Hematol; 2019 Nov; 98(11):2507-2521. PubMed ID: 31493004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell disease.
    Kato GJ; McGowan V; Machado RF; Little JA; Taylor J; Morris CR; Nichols JS; Wang X; Poljakovic M; Morris SM; Gladwin MT
    Blood; 2006 Mar; 107(6):2279-85. PubMed ID: 16291595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The interaction of alpha-thalassemia and homozygous sickle-cell disease.
    Higgs DR; Aldridge BE; Lamb J; Clegg JB; Weatherall DJ; Hayes RJ; Grandison Y; Lowrie Y; Mason KP; Serjeant BE; Serjeant GR
    N Engl J Med; 1982 Jun; 306(24):1441-6. PubMed ID: 6176865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.